https://sputniknews.in/20230614/cough-syrup-controversy-indian-agencies-to-investigate-bribe-angle-2477581.html
Cough Syrup Controversy: Indian Agencies to Investigate Bribe Angle
Cough Syrup Controversy: Indian Agencies to Investigate Bribe Angle
Sputnik India
Last October, 69 children died in Gambia after reportedly taking syrups which had been produced by India's Maiden Pharmaceuticals and had allegedly been... 14.06.2023, Sputnik India
2023-06-14T14:12+0530
2023-06-14T14:12+0530
2023-06-14T14:12+0530
political affairs
cough syrup
health
health crisis
health issues
the world health organization (who)
haryana
south africa
africa
pharmaceuticals
https://cdn1.img.sputniknews.in/img/07e6/0c/14/167008_0:114:1920:1194_1920x0_80_0_0_f30cfebdca5649deceebc6cf0fcfb048.jpg
India's Anti-Corruption Bureau (ACB) is to investigate whether there was any bribery angle to the recent Maiden Pharmaceuticals cough syrup scandal and whether samples tested in Indian laboratories were switched.According to media reports, ACB received a tip-off in a letter dated 29 April from a Haryana-based lawyer, Yashpal, who said that the state's drug controller, Manmohan Taneja, had been bribed INR 50Mln ($605,000) by a representative of Maiden Pharmaceuticals to switch the samples before they were tested in an Indian government laboratory.Yashpal, in his letter, alleged that Taneja had been taking bribes to approve products and issue drug licenses since 2021 but he didn't provide any evidence to support his claim.He also didn't name any local distributor or anyone for fear of retribution.Maiden Pharmaceuticals is accused of supplying adulterated cough syrups, which most likely killed 70 children in Gambia. After the incident, the World Health Organisation (WHO) found that the syrup had been contaminated and issued an alert against Maiden Pharma, but Indian laboratories contradicted WHO months later.However, the manufacturer's main factory and operations have been closed since October.No official statement has yet been made by the Haryana state government.
https://sputniknews.in/20230604/indian-govt-bans-14-drug-combinations-over-health-risk---heres-the-full-list-2325704.html
haryana
south africa
africa
Sputnik India
feedback.hindi@sputniknews.com
+74956456601
MIA „Rosiya Segodnya“
2023
Deexa Khanduri
https://cdn1.img.sputniknews.in/img/07e6/0c/13/138923_52:0:533:481_100x100_80_0_0_cadf23d341691fc65ff2b22fd1afe584.jpg
Deexa Khanduri
https://cdn1.img.sputniknews.in/img/07e6/0c/13/138923_52:0:533:481_100x100_80_0_0_cadf23d341691fc65ff2b22fd1afe584.jpg
News
en_IN
Sputnik India
feedback.hindi@sputniknews.com
+74956456601
MIA „Rosiya Segodnya“
Sputnik India
feedback.hindi@sputniknews.com
+74956456601
MIA „Rosiya Segodnya“
Deexa Khanduri
https://cdn1.img.sputniknews.in/img/07e6/0c/13/138923_52:0:533:481_100x100_80_0_0_cadf23d341691fc65ff2b22fd1afe584.jpg
world's pharmacy, generic drug exporter, drug export, gambia, children dies after consuming cough syrup, maiden pharmaceutical, bribe, anti-corruption bureau, acb, yashpal, manmohan taneja,
world's pharmacy, generic drug exporter, drug export, gambia, children dies after consuming cough syrup, maiden pharmaceutical, bribe, anti-corruption bureau, acb, yashpal, manmohan taneja,
Cough Syrup Controversy: Indian Agencies to Investigate Bribe Angle
Deexa Khanduri
Sputnik correspondent
Last October, 69 children died in Gambia after reportedly taking syrups which had been produced by India's Maiden Pharmaceuticals and had allegedly been contaminated with ethylene glycol and diethylene glycol.
India's Anti-Corruption Bureau (ACB) is to investigate whether there was any bribery angle to the recent Maiden Pharmaceuticals cough syrup scandal and whether samples tested in Indian laboratories were switched.
According to media reports, ACB received a tip-off in a letter dated 29 April from a Haryana-based lawyer, Yashpal, who said that the state's drug controller, Manmohan Taneja, had been bribed INR 50Mln ($605,000) by a representative of Maiden Pharmaceuticals to switch the samples before they were tested in an Indian government laboratory.
Yashpal, in his letter, alleged that Taneja had been taking bribes to
approve products and issue drug licenses since 2021 but he didn't provide any evidence to support his claim.
He also didn't name any local distributor or anyone for fear of retribution.
Maiden Pharmaceuticals is accused of supplying adulterated cough syrups, which most likely
killed 70 children in
Gambia. After the incident, the World Health Organisation (WHO) found that the syrup had been contaminated and issued an alert against Maiden Pharma, but Indian laboratories contradicted WHO months later.
However, the manufacturer's main factory and operations have been closed since October.
No official statement has yet been made by the Haryana state government.
